• News Archive
  • Simaster
  • Webmail
  • Directory
  • Crisis Center
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • News Report
  • The Chairman of Covid-19 Research and Innovation Consortium: UGM GeNose Can Be an Alternative for PCR Test

The Chairman of Covid-19 Research and Innovation Consortium: UGM GeNose Can Be an Alternative for PCR Test

  • 18 September 2020, 15:53 WIB
  • By: Natasa Adelayanti
  • 1243
Ketua Konsorsium Riset dan Inovasi Covid-19 Harapkan GeNose Buatan UGM Bisa Gantikan Uji PCR

Prof. dr. Ali Ghufron Mukti, M.Sc., Ph.D., as the Chairman of the Covid-19 Research and Innovation Consortium, said that since five months ago, the government had supported the acceleration of handling the Covid-19 pandemic in Indonesia through the development of medicinal products and medical devices. In its development process, the role of various universities, government agencies, and communities has involved the industries' development of drugs and medical devices. According to him, hopefully, this development is considered as the government's efforts to tackle the Covid-19 pandemic.

He appreciated UGM researchers who take part in developing several medical devices, such as a COVID detection tool via exhalation or GeNose, a ventilator to an antibody-based rapid test device.

In his remarks about this tool, which can detect COVID from breath, is a pretty good result of innovation and hopefully can replace the PCR test's role later. "Hopefully, it can replace the PCR role. Three countries have developed this kind of tool globally, namely America, Israel, and Indonesia," Ali Ghufron said in a webinar of the UGM FKKMK Health Innovation Exhibition on Thursday (17/9).

Concerning the development of the red and white vaccine, he said UGM and many other universities were also involved in developing vaccines whose raw materials came from existed-viruses in Indonesia. It is expected to encourage national independence in vaccine production. "We want the population immunity to be developed in a measured and systematic manner so that we must produce it," he said.

He estimates that if each person will receive two shots of vaccine doses, at least 350 million vaccines are needed. "If the average price is Rp. 200 thousand, Rp. Seventy trillion is needed for the cost of vaccines," he said.

On the other hand, Prof. dr. Triwibowo, Ph.D., Sp.MK., a member of the antibody-based rapid test innovation development team from FKKMK UGM, said that their team's rapid diagnostic tool was developed as the result of collaboration with UGM researchers and Airlangga University. "A rapid test tool for antibody-based non-PCR diagnosis so that it can be transferred out more quickly in the field, providing advocacy to stakeholders, and can even carry out the prevalence," he said.

He also added that even though it has started to be produced and tested in several places, the community's downstream process is not easy due to regulatory and administrative problems. "Although there has been a relaxation of policies, the field's implementation has not changed much," he added.

UGM Ventilator researcher, namely dr. Bowo Adiyanto, M.Sc., said that his party had successfully developed a ventilator for critical Covid-19 patients. According to him, the ventilator with the V-01 ICU Ventilator brand, in addition to helping patients still breathe, and their working power to adjust the patient's ability to breathe. "This ventilator can provide breath aid, and the working system can adjust the patient's breath," he said.

Author: Gusti Grehenson
Translator: Natasa A

Related News

  • The Chairman of Covid-19 Research and Innovation Consortium: UGM GeNose Can Be an Alternative for PCR Test

    Friday,18 September 2020 - 15:53
  • Minister of Research and Technology: GeNose Reducing Import Dependency on Covid-19 PCR Tools

    Monday,18 January 2021 - 9:12
  • GeNose Available at National Hospitals Soon

    Tuesday,09 February 2021 - 19:50
  • A Number of UGM Research Teams Involved in the Consortium of Covid-19 Research and Innovation

    Friday,05 June 2020 - 14:58
  • UGM Innovation: GeNose, Covid-19 Detection through Breathing

    Monday,14 September 2020 - 19:43

News Releases

  • 18,964 UGM Students Receive Scholarships, Director of Student Affairs Says 20 January 2023
    Universitas Gadjah Mada (UGM) annually allocates hundreds
    Salma
  • Prof. Budi Setiadi Daryono Recounts Origin of His Apple Melon Cultivar 'Hikapel' 16 January 2023
    In 2012, a team of researchers from the UGM Facult
    Salma
  • UGM Graduate Fajar Kelana Named Top 20 International James Dyson Award Winner 13 January 2023
    Fajar Sidik Abdullah Kelana, an alumnus of UGM and
    Salma
  • Chemical Eng. Students Win International Youth Ideas Competition 05 January 2023
    UGM Chemical Engineering students Andhirta Rukmarata Chani
    Salma
  • UGM Secures IDR 67 Billion From 2022 Kedaireka Matching Fund, Most Among Other Universities 30 December 2022
    Universitas Gadjah Mada (UGM) has topped the list of unive
    Salma

Event

No latest event at this time

Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2023 Universitas Gadjah Mada

PRIVACY POLICYCONTACT